Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Revista Cubana de Medicina General Integral ; 37, 2021.
Article in Spanish | Scopus | ID: covidwho-1589943

ABSTRACT

Introduction: Humanity has been surprised in 2020 by the proliferation of a global pandemic produced by SARS-CoV-2. The COVID-19 is a disease defined by the World Health Organization as an infectious disease with a high level of contagion. There are many impacts that this disease has generated in the field of health, society and the economy, however, the impact for those who cannot survive the virus due to various risk factors is much greater. Objective: To identify the knowledge of medical personnel of the main sequelae faced by patients who overcome COVID-19. Methods: The databases included in the LILACS, EBSCO and HINARI services were consulted, and very good coverage was achieved, both in Cuba, Latin America and the Caribbean. as in the rest of the world. Web sites on the Internet that should be consulted were also visited due to their prestige and leadership on the subject. Conclusions: Being a pandemic in progress, determining the long-term effects that this disease can cause is a challenge, although the immediate sequelae in patients recovered after having undergone treatment are evidenced in multiple investigations. © 2021, Editorial Ciencias Medicas. All rights reserved.

2.
Rev Esp Anestesiol Reanim (Engl Ed) ; 68(10): 597-601, 2021 12.
Article in English | MEDLINE | ID: covidwho-1510237

ABSTRACT

Iatrogenic tracheal rupture (ITR) is a serious complication secondary to procedures such as emergent orotracheal intubation or tracheostomy, among others. The management of ITR depends on the size, extension and location of the injury, along with the patient's respiratory status and comorbidities. The priority of treatment is to keep the airway permeable to ensure adequate ventilation. We present the case of a tracheal rupture after performing a percutaneous tracheostomy, in a patient diagnosed with severe acute respiratory distress syndrome secondary to bilateral interstitial pneumonia due to SARS-Cov-2. The issues are discussed, such as the management (conservative vs. surgical) depending on the features of the injury and the patient, in the extraordinary context that the COVID-19 pandemic has entailed.


Subject(s)
COVID-19 , Respiratory Distress Syndrome , Humans , Iatrogenic Disease , Pandemics , Respiratory Distress Syndrome/etiology , Rupture , SARS-CoV-2 , Trachea/diagnostic imaging
3.
J Eur Acad Dermatol Venereol ; 35(9): 1865-1873, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1236393

ABSTRACT

BACKGROUND: Descriptions of cutaneous findings associated with COVID-19 have not been consistently accompanied by histopathology or confirmatory testing for SARS-CoV-2. OBJECTIVE: To describe and classify the cutaneous findings with supporting histopathology of confirmed COVID-19 inpatients. METHODS: We included consecutive inpatients with a confirmed diagnosis of COVID-19 for whom a dermatology consult was requested. A skin biopsy was performed in all cases. Skin findings were classified as being compatible with a cutaneous manifestation of COVID-19 or as representing a distinct clinical entity. RESULTS: Twenty-eight patients were studied in whom thirty-one dermatologic diagnoses were made. Twenty-two of the dermatoses were compatible with a cutaneous manifestation of COVID-19; nine entities were not associated with infection by SARS-CoV-2. The most common COVID-19-associated pattern was an exanthematous presentation. In four patients, a new pattern was observed, characterized by discrete papules with varied histopathological findings including a case of neutrophilic eccrine hidradenitis. No cases of pernio-like lesions were identified. Skin findings not associated with COVID-19 represented 29% of diagnoses and included Malassezia folliculitis, tinea, miliaria and contact dermatitis. LIMITATIONS: There is no gold-standard test to distinguish between viral exanthems and drug reactions. CONCLUSION: A histopathological study is critical before attributing skin findings to a manifestation of COVID-19.


Subject(s)
COVID-19 , Chilblains , Skin Diseases , Humans , SARS-CoV-2 , Skin
4.
Rev Esp Anestesiol Reanim (Engl Ed) ; 2020 Oct 26.
Article in English, Spanish | MEDLINE | ID: covidwho-1179989

ABSTRACT

Iatrogenic tracheal rupture is a serious complication secondary to procedures such as emergent orotracheal intubation or tracheostomy, among others. The management of iatrogenic tracheal rupture depends on the size, extension and location of the injury, along with the patient's respiratory status and comorbidities. The priority of treatment is to keep the airway permeable to ensure adequate ventilation. We present the case of a tracheal rupture after performing a percutaneous tracheostomy, in a patient diagnosed with severe acute respiratory distress syndrome secondary to bilateral interstitial pneumonia due to SARS-CoV-2. The issues are discussed, such as the management (conservative vs. surgical) depending on the features of the injury and the patient, in the extraordinary context that the COVID-19 pandemic has entailed.

SELECTION OF CITATIONS
SEARCH DETAIL